Redox cycling in MCF-7 human breast cancer cells by antitumor agents based on mitozantrone (Q42494000)

1 November 2017

title

Redox cycling in MCF-7 human breast cancer cells by antitumor agents based on mitozantrone (English)

1 reference

1 November 2017

Fisher GR

1

1 reference

1 November 2017

Brown JR

series ordinal

2

1 reference

1 November 2017

Patterson LH

series ordinal

3

1 reference

1 November 2017

publication date

1 January 1989

1 reference

Free radical research communications

1 November 2017

published in

1 reference

1 November 2017

volume

7

1 reference

1 November 2017

issue

3-6

1 reference

1 November 2017

page(s)

221-226

1 reference

Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10715768909087945

Intensive single-agent mitoxantrone for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715768909087945

The effect of the anthrapyrazole antitumour agent CI941 on rat liver microsome and cytochrome P-450 reductase mediated free radical processes. Inhibition of doxorubicin activation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715768909087945

Bis(alkylamino)anthracenedione antineoplastic agent metabolic activation by NADPH-cytochrome P-450 reductase and NADH dehydrogenase: diminished activity relative to anthracyclines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10715768909087945

A human cell line from a pleural effusion derived from a breast carcinoma

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1093/JNCI/51.5.1409

Identifiers

DOI

10.3109/10715768909087945

1 reference

1 November 2017

1 reference